The association between leptin concentration and blood coagulation: Results from the NEO study.


Journal

Thrombosis research
ISSN: 1879-2472
Titre abrégé: Thromb Res
Pays: United States
ID NLM: 0326377

Informations de publication

Date de publication:
04 2020
Historique:
received: 06 10 2019
revised: 02 01 2020
accepted: 19 01 2020
pubmed: 13 2 2020
medline: 22 6 2021
entrez: 13 2 2020
Statut: ppublish

Résumé

The adipocyte-derived hormone leptin has been associated with altered blood coagulation in in vitro studies. However, it is unclear whether this association is relevant in vivo and to what extent this association is influenced by total body fat. Therefore, we aimed to examine the association between serum leptin and blood coagulation while taking total body fat into account in a population-based cohort study. We performed a cross-sectional analysis with baseline measurements of 5797 participants of the Netherlands Epidemiology of Obesity (NEO) study, a population-based cohort of middle-aged men and women. We examined associations between serum leptin concentration and coagulation factor concentrations and parameters of platelet activation in linear regression analyses. All analyses were adjusted for multiple covariates, including total body fat. In multivariable adjusted analyses a 1 μg/L higher serum leptin concentration was associated with a 0.22 IU/dL (95% CI: 0.11, 0.32) higher FVIII concentration and a 0.20 IU/dL (95% CI: 0.14, 0.27) higher FIX concentration (3.5 IU/dL FVIII and 3.2 IU/dL FIX per SD leptin). Serum leptin concentration was not associated with FXI, fibrinogen, platelet count, mean platelet volume and platelet distribution width in multivariable adjusted analyses. This study showed that serum leptin concentration was associated with higher concentrations of FVIII and FIX in an observational study, which could be clinically relevant.

Sections du résumé

BACKGROUND
The adipocyte-derived hormone leptin has been associated with altered blood coagulation in in vitro studies. However, it is unclear whether this association is relevant in vivo and to what extent this association is influenced by total body fat. Therefore, we aimed to examine the association between serum leptin and blood coagulation while taking total body fat into account in a population-based cohort study.
METHODS
We performed a cross-sectional analysis with baseline measurements of 5797 participants of the Netherlands Epidemiology of Obesity (NEO) study, a population-based cohort of middle-aged men and women. We examined associations between serum leptin concentration and coagulation factor concentrations and parameters of platelet activation in linear regression analyses. All analyses were adjusted for multiple covariates, including total body fat.
RESULTS
In multivariable adjusted analyses a 1 μg/L higher serum leptin concentration was associated with a 0.22 IU/dL (95% CI: 0.11, 0.32) higher FVIII concentration and a 0.20 IU/dL (95% CI: 0.14, 0.27) higher FIX concentration (3.5 IU/dL FVIII and 3.2 IU/dL FIX per SD leptin). Serum leptin concentration was not associated with FXI, fibrinogen, platelet count, mean platelet volume and platelet distribution width in multivariable adjusted analyses.
DISCUSSION
This study showed that serum leptin concentration was associated with higher concentrations of FVIII and FIX in an observational study, which could be clinically relevant.

Identifiants

pubmed: 32050106
pii: S0049-3848(20)30030-X
doi: 10.1016/j.thromres.2020.01.021
pii:
doi:

Substances chimiques

LEP protein, human 0
Leptin 0

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

44-48

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors state that they have no conflict of interest.

Auteurs

D T P Buis (DTP)

Clinical Epidemiology, C7-P, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, the Netherlands. Electronic address: d.t.p.buis@lumc.nl.

T Christen (T)

Clinical Epidemiology, C7-P, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, the Netherlands.

R A J Smit (RAJ)

Clinical Epidemiology, C7-P, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, the Netherlands.

R de Mutsert (R)

Clinical Epidemiology, C7-P, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, the Netherlands.

J W Jukema (JW)

Clinical Epidemiology, C7-P, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, the Netherlands.

S C Cannegieter (SC)

Clinical Epidemiology, C7-P, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, the Netherlands.

W M Lijfering (WM)

Clinical Epidemiology, C7-P, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, the Netherlands.

F R Rosendaal (FR)

Clinical Epidemiology, C7-P, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH